Clinical Trial Update: Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intranasal oxytocin to reduce stress in caregivers of people with dementia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: University of Nebraska | Conditions: Stress | Phase 2 | Status: RECRUITING